Ge Yuan, O'Shea Donal F
Department of Chemistry, RCSI, University of Medicine and Health Sciences, 123 St Stephen's Green, Dublin 2, D02 YN77 Dublin, Ireland.
Molecules. 2024 Dec 18;29(24):5964. doi: 10.3390/molecules29245964.
The term "fluorescence" was first proposed nearly two centuries ago, yet its application in clinical medicine has a relatively brief history coming to the fore in the past decade. Nowadays, as fluorescence is gradually expanding into more medical applications, fluorescence image-guided surgery has become the new arena for this technology. It allows surgical teams to real-time visualize target tissues or anatomies intraoperatively to increase the precision of resection or preserve vital structures during open or laparoscopic surgeries. In this review, we introduce the concept of near-infrared fluorescence guided surgery, discuss the recent and ongoing clinical trials of molecular fluorophores (indocyanine green, 5-aminolevulinic acid, methylene blue, IR-dye 800CW, pafolacianine) and their surgical goals, highlight key chemical and medical factors for imaging agent optimization, deliberate challenges and potential advantages, and propose a framework for integrating this technology into routine surgical care in the near future. The notable clinical achievements of these fluorophores over the past decade strongly indicates that the future of fluorescence in surgery is bright with many more patient benefits to come.
“荧光”一词近两个世纪前首次被提出,但其在临床医学中的应用历史相对较短,在过去十年才崭露头角。如今,随着荧光逐渐拓展至更多医学应用领域,荧光图像引导手术已成为这项技术的新舞台。它使手术团队能够在术中实时可视化目标组织或解剖结构,以提高开放手术或腹腔镜手术中切除的精准度或保护重要结构。在这篇综述中,我们介绍近红外荧光引导手术的概念,讨论分子荧光团(吲哚菁绿、5-氨基乙酰丙酸、亚甲蓝、IR-染料800CW、帕氟拉西阿宁)近期及正在进行的临床试验及其手术目标,强调成像剂优化的关键化学和医学因素,探讨挑战与潜在优势,并提出在不久的将来将这项技术整合到常规手术护理中的框架。过去十年这些荧光团显著的临床成就有力地表明,手术中荧光的未来一片光明,将为更多患者带来益处。